Skip to main content
Top
Published in: Diabetologia 5/2017

01-05-2017 | Editorial

Precision diabetes: a realistic outlook on a promising approach

Author: Sally M. Marshall

Published in: Diabetologia | Issue 5/2017

Login to get access

Excerpt

Precision medicine, the tailoring of healthcare based on an individual’s genetics, lifestyle and environment, is not a new concept. Throughout the history of medicine, clinicians have called on available resources to determine the optimum treatment for patients. A common example is the selection of specific blood types for blood transfusions on the basis of the recipient’s blood group, a procedure that became routine following the discovery of human blood groups by Karl Landsteiner in 1901 [1]. Glasses are another example: lenses have been tailored to an individual’s visual ability since circa 1284 [2]. By adopting a precision medicine approach, healthcare is made more effective, safer and more cost-efficient. …
Literature
1.
go back to reference Bayne-Jones S (1931) Dr. Karl Landstteiner Nobel Prize Laureate in Medicine, 1930. Science 73:599–604CrossRefPubMed Bayne-Jones S (1931) Dr. Karl Landstteiner Nobel Prize Laureate in Medicine, 1930. Science 73:599–604CrossRefPubMed
2.
go back to reference Ilardi V (2007) The invention of spectacles revisited. In: Renaissance vision from spectacles to telescopes. American Philosophical Society, Philadelphia, p 8 Ilardi V (2007) The invention of spectacles revisited. In: Renaissance vision from spectacles to telescopes. American Philosophical Society, Philadelphia, p 8
3.
go back to reference Tattersall RB (1974) Mild familial diabetes with dominant inheritance. Q J Med 170:339–357 Tattersall RB (1974) Mild familial diabetes with dominant inheritance. Q J Med 170:339–357
8.
go back to reference Bollag G, Tsai J, Zhang J et al (2012) Vemurafenib: the first drug approved for BRAF-mutant cancer. Nat Rev Drug Discov 11:873–886CrossRefPubMed Bollag G, Tsai J, Zhang J et al (2012) Vemurafenib: the first drug approved for BRAF-mutant cancer. Nat Rev Drug Discov 11:873–886CrossRefPubMed
11.
go back to reference Franks PW, Poveda A (2017) Lifestyle and precision diabetes medicine: will genomics help optimise the prediction, prevention and treatment of type 2 diabetes through lifestyle therapy? Diabetologia. doi:10.1007/s00125-017-4207-5 Franks PW, Poveda A (2017) Lifestyle and precision diabetes medicine: will genomics help optimise the prediction, prevention and treatment of type 2 diabetes through lifestyle therapy? Diabetologia. doi:10.​1007/​s00125-017-4207-5
Metadata
Title
Precision diabetes: a realistic outlook on a promising approach
Author
Sally M. Marshall
Publication date
01-05-2017
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 5/2017
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-017-4244-0

Other articles of this Issue 5/2017

Diabetologia 5/2017 Go to the issue